Itraconazole 65 MG
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Post Graduate Institute of Medical Education and Research, Chandigarh
Overview
Itraconazole 65 MG is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Itraconazole 65 MG clinical trials
Explore related
Medical disclaimer. This page summarizes research about Itraconazole 65 MG for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.